Focused on developing chimeric antigen receptor T‑cell (CAR‑T) immunotherapies, the company specialized in engineering patients’ immune cells to target and destroy cancer. Its pipeline centered on treatments for leukemia and lymphoma, placing it among a wave of biotechnology firms advancing cell‑bas...
2 members of Congress have disclosed 5 trades in Juno Therapeutics Inc Com (JUNO), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 3 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2019-04-02 | KENNY MARCHANT | buy | $1K – $15K |
| 2016-12-27 | CHARLES J. "CHUCK" FLEISCHMANN | sell | $1K – $15K |
| 2016-08-18 | CHARLES J. "CHUCK" FLEISCHMANN | sell | $1K – $15K |
| 2016-01-29 | CHARLES J. "CHUCK" FLEISCHMANN | sell | $1K – $15K |
| 2015-07-10 | CHARLES J. "CHUCK" FLEISCHMANN | buy | $1K – $15K |